Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
WASHINGTON, D.C. and MINNEAPOLIS - Sept. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve® System...
MINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora(TM) Noncompliant Balloon...
MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. (NYSE: MDT) was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index...
MINNEAPOLIS - Sept. 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the...
MINNEAPOLIS - Sept. 3, 2014 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation...
MINNEAPOLIS - Sept 2, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference,...
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial...
MEMPHIS, TN - Aug. 28, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of...
TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction...
MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...
MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva®...
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...
MINNEAPOLIS - August 21, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the company's common stock. The quarterly dividend...
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 21, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for...
SÃO PAULO--(BUSINESS WIRE)--Aug. 20, 2014-- Covidien plc (NYSE: COV) today officially opened its Covidien Center of Innovation Brazil (CCI Brazil), further expanding its educational and research...
MINNEAPOLIS - August 20, 2014 - Greater Twin Cities United Way today strengthened their long-standing commitment to improving the health and well-being of Twin Cities' communities by teaming up...
MINNEAPOLIS - Aug. 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2015, which ended July 25, 2014. The company reported worldwide...
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 18, 2014-- Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a...
MINNEAPOLIS - August 11, 2014 - Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run as a team in the Medtronic Twin...
MINNEAPOLIS - Aug. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2015 on Tuesday, August 19, 2014. A news release...
MINNEAPOLIS - Aug. 7, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa® Model 4298 quadripolar...
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS - August 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the launch of the NuVent(TM) EM Sinus Dilation System for the Fusion® ENT Navigation System, developed and manufactured...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of Visualase, Inc., a privately held company based in Houston, TX, that develops and...
MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc...
DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the third quarter of fiscal 2014. Third-quarter net sales of $2.69 billion...
DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014-- Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to...
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on...
DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 16, 2014-- Overcoming a significant roadblock to predictable ablation of soft tissue, Covidien plc (NYSE:COV) has unveiled an advanced ablation system that...
DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 14, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien plc today announced the launch of its EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in Australia and New Zealand. The...
BOSTON-- (BUSINESS WIRE)--Covidien today announced the commercial launch of its next generation TrellisTM peripheral infusion system. The redesigned system continues to be the only...
DUBLIN, Ireland--(BUSINESS WIRE)--FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TA KEOVER RULES, 2013 DEALINGS BY OFFERORS,...
MINNEAPOLIS - July 2, 2014 - As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. (NYSE:MDT) today announced the results of the OpT2mise...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 30, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE:COV) (the “Company”) confirms that, as of the close of business...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 26, 2014-- Covidien plc (NYSE: COV) will report third-quarter fiscal 2014 results on July 25. The company will host a conference call for investors at 8:30...
MINNEAPOLIS - June 25, 2014 - Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial have been published in...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Covidien (NYSE: COV) today announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon...
DUBLIN--(BUSINESS WIRE)--Jun. 24, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European...
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
MINNEAPOLIS and NICE, France - June 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced preliminary results from the first human implants of the world's smallest pacemaker, the Micra(TM)...
MINNEAPOLIS, USA and NICE, FRANCE - June 18, 2014 - New data from the Medtronic, Inc. (NYSE: MDT) Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial fibrillation (AF)-related...
MINNEAPOLIS, USA and NICE, FRANCE – June 18, 2014 – New data from the Medtronic, Inc. (NYSE: MDT) Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial fibrillation (AF)-related...
MINNEAPOLIS - June 17, 2014 - Medtronic today announced the launch of HealthRise, a five-year, $17-million (USD) Medtronic Philanthropy program that supports community-based demonstration projects...
MINNEAPOLIS - June 16, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT) approved yesterday a 9 percent increase in its cash dividend, raising the quarterly amount to $0.305 per share...
MINNEAPOLIS AND DUBLIN - June 15, 2014 - Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology...
PARIS, FRANCE, AND MINNEAPOLIS, MN - June 14, 2014 - Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to...
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS - June 12, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for patients...
MINNEAPOLIS - June 11, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT), announced that the company's annual meeting of shareholders will be held at 10:30 a.m. CDT on Thursday, Aug....
MINNEAPOLIS - Date - Moving toward U.S. market introduction of its novel medical device to treat peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that it recently submitted...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 10, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro catheter - the...
MINNEAPOLIS - June 10, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Healthcare Conference on Tuesday,...
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS -- Jun. 5, 2014 -- Medtronic, Inc. (NYSE: MDT) shared during its Investor Conference today in New York City an overview of the state of its business and strategies for future growth...
HeartWare International, Inc. (Nasdaq: HTWR) announced that on June 3, 2014 it received a warning letter from the U.S. Food and Drug Administration (FDA) resulting from an inspection of the...
MINNEAPOLIS -- Jun. 4, 2014 -- Continuing to expand its market-leading portfolio of endovascular solutions, Medtronic, Inc. (NYSE: MDT) announced today that two recently Food and Drug...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
TOLOCHENAZ, SWITZERLAND - June 3, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the European launch of MiniMed® Duo(TM), the world's first two-in-one breakthrough that combines a glucose...
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 3, 2014-- Covidien plc, a leading global provider of health care products and recognized innovator in patient monitoring and respiratory care devices, today...
MINNEAPOLIS - June 3, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 35th annual Goldman Sachs Global Healthcare...
MINNEAPOLIS - June 2, 2014 - Medtronic, Inc. (NYSE: MDT), today announced CE (Conformité Européenne) Mark and commercial launch of the Advisa® and Ensura SR MRI(TM) SureScan® single chamber...
MINNEAPOLIS - June 2, 2014- Medtronic, Inc. (NYSE: MDT) today opened 2014 award applications for the Bakken Invitation, a global program designed to celebrate and connect people who, with the help...
HeartWare International, Inc. (Nasdaq: HTWR) today announced issuance of a clinician and patient reminder concerning the Urgent Medical Device Correction distributed to all of its clinical sites...
PARIS and MINNEAPOLIS - May 21, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed new data showing that patients treated with the CoreValve® System experienced positive clinical outcomes in the...
PARIS--(BUSINESS WIRE)--May 22, 2014-- Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial...
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation (NYSE:EW). Under the terms of the...
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2014, which ended April 25, 2014. The company reported worldwide...
MINNEAPOLIS -- May 20, 2014 -- Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité
MINNEAPOLIS - May 19, 2014 - Medtronic, Inc. (NYSE:MDT) applauds the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) on their updated...
BETHESDA, MD and DUBLIN, Ireland – May 19, 2014 – Covidien, a global health care technology and medical supplies provider, and the National Association of Community Health Centers (NACHC)...
MINNEAPOLIS - May 19, 2014 - Medtronic, Inc. (NYSE: MDT) announced the appointment of Brad Lerman as senior vice president, general counsel and corporate secretary effective May 27, 2014. In this...
TEMPE, ARIZ. - May 14, 2014 - The Medtronic Tempe Campus, a manufacturing site for the world's leading medical technology company, has been named 2014 Manufacturer of the Year by the Arizona...
MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the selection of Hooman Hakami as executive vice president and group president of the Medtronic Diabetes Group, the global...
MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, May 20, 2014. A news release will...
MINNEAPOLIS - May 1, 2014 - Medtronic today announced that 10 students have been selected as 2014 Medtronic Wallin Scholars. Each will receive a four-year scholarship totaling $16,000, as well as...
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing...
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS and SAN FRANCISCO - May 9, 2014 - Medtronic, Inc. (NYSE: MDT) today released study findings that show heart failure patients who have limited options for implanted device therapy may...
MINNEAPOLIS - May 9, 2014 - Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Thursday, June 5, 2014, in New York City from 8:30 a.m. to approximately 1:00 p.m....
ISTANBUL--(BUSINESS WIRE)--May 7, 2014-- Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation
MINNEAPOLIS - MAY 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has agreed with certain plaintiffs' counsel to settle their inventories of filed and unfiled product liability...
DUBLIN, Ireland--(BUSINESS WIRE)--May 6, 2014-- Covidien plc (NYSE: COV) will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on May 14. Bryan Hanson, group...
MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...
HeartWare International, Inc. (Nasdaq: HTWR), today issued a voluntary Urgent Medical Device Correction related to all HeartWare® Ventricular Assist System batteries, product codes 1650 and...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS, MAY 1, 2014 - Medtronic, Inc. (NYSE:MDT) today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker,...
DUBLIN, Ireland--(BUSINESS WIRE)--May 1, 2014-- Covidien plc (NYSE: COV) will present at the Deutsche Bank 39th Annual Health Care Conference in Boston on May 8. Charles J. Dockendorff, executive...
MINNEAPOLIS - April 29, 2014 -Medtronic, Inc. (NYSE: MDT) today announced five-year follow-up data demonstrating the safety and performance of the Medtronic 3f Enable® Aortic Bioprosthesis - the...
TORONTO and MINNEAPOLIS - April 29, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were...
MINNEAPOLIS - April 28, 2014 - Medtronic has been recognized as a top U.S. corporate citizen by Corporate Responsibility Magazine. The publication's 100 Best Corporate Citizens List, released this...
DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion...
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended March 31, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on...